DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▼ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0027651 | Neoplasms | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0002395 | Alzheimer's Disease | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0085669 | Acute leukemia | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0033578 | Prostatic Neoplasms | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0005283 | beta Thalassemia | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0687720 | Central Diabetes Insipidus | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0020615 | Hypoglycemia | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0020501 | Primary Hyperoxaluria | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0520459 | Necrotizing Enterocolitis | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0020459 | Hyperinsulinism | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0006826 | Malignant Neoplasms | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0086543 | Cataract | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0009691 | Congenital cataract | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C1306459 | Primary malignant neoplasm | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0376358 | Malignant neoplasm of prostate | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0023467 | Leukemia, Myelocytic, Acute | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0525045 | Mood Disorders | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0006142 | Malignant neoplasm of breast | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0004364 | Autoimmune Diseases | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0345904 | Malignant neoplasm of liver | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0006826 | Malignant Neoplasms | CRYBG3 | 131544 | crystallin beta-gamma domain containing 3 | Q68DQ2 |
C0027651 | Neoplasms | CRYBG3 | 131544 | crystallin beta-gamma domain containing 3 | Q68DQ2 |
C1306459 | Primary malignant neoplasm | CRYBG3 | 131544 | crystallin beta-gamma domain containing 3 | Q68DQ2 |
C0684249 | Carcinoma of lung | CRYBG3 | 131544 | crystallin beta-gamma domain containing 3 | Q68DQ2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024